Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 5 of 5 for “"SMN2"”.
-
MOTONEURON MAINTENANCE DEFECTS AND NON-CELL AUTONOMOUS CONTRIBUTIONS BY SCHWANN CELLS IN ZEBRAFISH MUTANT AND MORPHANT MODELS FOR SPINAL MUSCULAR ATROPHY
… (SMA) patients. SMN is encoded by SMN1 and SMN2 which differ in a C6T nucleotide leading to differential splicing of exon 7. My novel zebrafish smn2 mutant established that C6T transition in hSMN2 disrupts an exonic splicing enhancer to cause aberrant splicing. The smn2 mutant exhibits …
-
Design, synthesis, and analysis of conjugated activators for modulation of alternative splicing
… gene. A nearly identical copy of the gene, SMN2, encodes an identical protein but contains a C-->T transition on the ESE of exon 7, disrupting SR protein binding and resulting in substantial exon 7 skipping. Significant research efforts have focused on redirecting the splicing pattern of …
-
Identifying modifier genes in SMA model mice
… spinal muscular atrophy. Extra copies of the SMN2 gene modify the severity of spinal muscular atrophy. Mutations in SMN1 (Motor Neuron 1) mainly causes SMA (Autosomal recessive inheritance). SMN1 gene mutations lead to a shortage of the SMN protein and SMN protein forms SMN complex which take …
-
Untersuchungen zum molekularen Pathomechanismus der SMA durch Anaylse der Smn-Interaktionspartner hnRNP-R und hnRNP-Q
… haben, gibt es beim Menschen eine zweite Kopie (SMN2). Das Genprodukt dieser zweiten Kopie wird am C-Terminus bevorzugt alternativ gespleißt. Es bringt nur eine kleine Menge des vollständigen SMN Proteins hervor. Der Grund, warum eine reduzierte Menge des ubiquitär exprimierten SMN Proteins …
-
Development and Validation of Quantitative PCR Assays for DNA-Based Newborn Screening of 22q11.2 Deletion Syndrome, Spinal Muscular Atrophy, Severe Combined Immunodeficiency and Congenital Cytomegalovirus Infection
The development of new high throughput technologies able to multiplex disease biomarkers as well as advances in medical treatments has lead to the recent expansion of the newborn screening panel to include DNA-based targets. Four rare disorders; deletion 22q11.2 syndrome and Spinal Muscular Atrophy …